| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 09/08/1999 | EP0939625A1 2-cyclopenten-1-one as an inducer of hsp70 |
| 09/08/1999 | EP0939621A1 Inhibition of bcl-2 protein expression by liposomal antisense oligodeoxynucleotides |
| 09/08/1999 | EP0799205B1 1,4,4-(trisubstituted)cyclohex-1-ene derivatives as pde iv- and tnf-inhibitors |
| 09/08/1999 | EP0791004B1 Acylated benzylglycosides as inhibitors of smooth muscle cell proliferation |
| 09/08/1999 | EP0749415B1 Benzamide analogs, useful as parp (adp-ribosyltransferase, adprt) dna repair enzyme inhibitors |
| 09/08/1999 | EP0730594B1 9-HYDROXY-PYRIDO [1,2-a]PYRIMIDIN-4-ONE ETHER DERIVATIVES |
| 09/08/1999 | EP0722460B1 Derivatives of peptides therapeutically active in the cascade sequence for blood coagulation, process for their preparation and pharmaceutical compositions containing same |
| 09/08/1999 | EP0656906B1 A novel endothelial cell molecule mediating lymphocyte binding in man |
| 09/08/1999 | CN1228092A Purine derivatives and their use as anti-coagulants |
| 09/08/1999 | CN1228091A Substituted 6,6-hetero-bicyclic derivatives |
| 09/08/1999 | CN1228087A Substituted pyrimidine derivatives and their pharmaceutical use |
| 09/08/1999 | CN1228027A Method to obtain oestrogens from mare's urine |
| 09/08/1999 | CN1228024A Use of K-252A derivative for treatment of peripheral or central nerve disorders, and cytokine overproduction |
| 09/08/1999 | CN1227842A Penems and their derivatives |
| 09/08/1999 | CN1227841A Piperazine derivatives as 5-HT1A antagonists |
| 09/08/1999 | CN1227727A Multifunctional nutritive liquid and its producing method |
| 09/07/1999 | US5948933 Tropane analogs and methods for inhibition of monoamine transport |
| 09/07/1999 | US5948902 Antisense oligonucleotides to human serine/threonine protein phosphatase genes |
| 09/07/1999 | US5948809 (-) cis-6(S)-phenyl-5(R) 4-(2-pyrrolidin-1-yl ethoxy) phenyl!-5,6,7,8-tetrahydronaphthalen-2-ol-D-tartrate |
| 09/07/1999 | US5948803 Improve the insulin resistance and have potent hypoglycemic effect and lipid-lowering effect |
| 09/07/1999 | US5948802 Stroke, anticonvulsants, antiepilepic agents, antiasthma agents, migraines, nervous system disorders, sexual disorders, incotinence |
| 09/07/1999 | US5948796 Benzo B!thiophene compounds, intermediates, formulations, and methods |
| 09/07/1999 | US5948789 Process for synthesis of substituted sulphoxides |
| 09/07/1999 | US5948784 Nephritis |
| 09/07/1999 | US5948778 Difluoro statone antiviral analogs |
| 09/07/1999 | US5948777 Cannabinoid receptor agonists |
| 09/07/1999 | US5948768 Treatment of otitis media by sublingual administration of DNA |
| 09/07/1999 | US5948766 Use of tasteless, hydrolyzed collagen and agent containing the same |
| 09/07/1999 | US5948764 Methods for treatment of multiple sclerosis utilizing peptide analogues of human myelin basic protein |
| 09/07/1999 | US5948749 Mixture of a divinylbenzene-styrene copolymer powder absorbent and biological active peptide |
| 09/07/1999 | US5948669 As probes and primers; for diagnosis and treatment of osteoporosis, oral diseases, paget's disease; antiarthritic agents, anticarcinogenic/antitumor/antimetastasis agents |
| 09/07/1999 | US5948657 Phenylalanyl-tRNA synthetase from Staphylococcus aureus |
| 09/07/1999 | US5948642 Polynucleotide from staphylococcus aureus which codes for resolvase polypeptide; for diagnosis of infections; as bactericides; for screening for novel antibiotics; treatment of toxic shock syndrome |
| 09/07/1999 | US5948640 Mammalian additional sex combs (mammalian Asx) acts as a tumor suppressor |
| 09/07/1999 | US5948609 Oxygen-transporting albumin-based blood replacement composition and blood volume expander |
| 09/07/1999 | US5948436 Protease inhibitor |
| 09/07/1999 | US5948428 Compositions and therapeutic methods using morphogenic proteins and stimulatory factors |
| 09/07/1999 | US5948407 Oral induction of tolerance to parenterally administered non-autologous polypeptides |
| 09/07/1999 | US5948402 Method of using IL-11 for treating antibiotic induced diarrhea |
| 09/07/1999 | US5947708 Axial flow valve system for linear compressor |
| 09/07/1999 | CA2098944C Novel pyrazole derivatives, method of preparing them and pharmaceutical compositions in which they are present |
| 09/07/1999 | CA2016646C Arylsulphonamides |
| 09/07/1999 | CA1340722C Pharmaceutical composition for the treatment of high blood pressure |
| 09/04/1999 | CA2231005A1 Cyclin dependent kinase inhibitor |
| 09/02/1999 | WO1999043840A1 Self-regulated apoptosis of inflammatory cells by gene therapy |
| 09/02/1999 | WO1999043839A1 Vaccines, immunotherapeutics and methods for using the same |
| 09/02/1999 | WO1999043832A2 Human proteinase molecules |
| 09/02/1999 | WO1999043829A2 Cell cycle related proteins |
| 09/02/1999 | WO1999043813A1 Modified ciliary neurotrophic factor, method of making and methods of use thereof |
| 09/02/1999 | WO1999043807A2 Human channel-related molecules |
| 09/02/1999 | WO1999043806A1 Human smn-like protein |
| 09/02/1999 | WO1999043791A2 Diisopropyl fluorophosphatase and the utilization and production thereof |
| 09/02/1999 | WO1999043787A2 A living chimeric skin replacement |
| 09/02/1999 | WO1999043675A1 6,9-disubstituted 2-[trans-(4- aminocyclohexyl) amino]purines |
| 09/02/1999 | WO1999043672A1 Inhibitors of phospholipase a2 |
| 09/02/1999 | WO1999043670A1 Benzylpiperazinyl- and benzylpiperidinyl ethanone derivatives, their preparation and their use as dopamine d4 receptor antagonists |
| 09/02/1999 | WO1999043663A1 N-[(substituted five-membered di- or triaza diunsaturated ring)carbonyl] guanidine derivatives for the treatment of ischemia |
| 09/02/1999 | WO1999043661A2 Substituted cycloalkyl-4-oxonicotinic carboxamides; gaba brain receptor ligands |
| 09/02/1999 | WO1999043657A1 2-arylethyl-(piperidin-4-ylmethyl)amine derivatives as muscarinic receptor antagonists |
| 09/02/1999 | WO1999043654A2 Inhibitors of phospholipase enzymes |
| 09/02/1999 | WO1999043651A2 Inhibitors of phospholipase enzymes |
| 09/02/1999 | WO1999043646A1 Cyclohexanediole derivatives |
| 09/02/1999 | WO1999043642A1 Phenylalanine derivatives as inhibitors of alpha4 integrins |
| 09/02/1999 | WO1999043361A1 Glp-2 derivatives with helix-content exceeding 25 %, forming partially structured micellar-like aggregates |
| 09/02/1999 | WO1999043350A1 Use of skin penetration enhancers and barrier disruption agents to enhance the transcutaneous immune response induced by adp-ribosylating exotoxin |
| 09/02/1999 | WO1999043343A1 Novel peptide copolymer compositions |
| 09/02/1999 | WO1999043341A1 Glp-1 derivatives with helix-content exceeding 25 %, forming partially structured micellar-like aggregates |
| 09/02/1999 | WO1999043339A1 A pharmaceutical preparation comprising an angiotensin ii type 2 receptor agonist, and use thereof |
| 09/02/1999 | WO1999043334A1 Use of rhamnolipids in wound healing, treating burn shock, atherosclerosis, organ transplants, depression, schizophrenia and cosmetics |
| 09/02/1999 | WO1999043325A1 Preventives or remedies for diseases in association with vascular functional anomaly relating to insulin resistance |
| 09/02/1999 | WO1999043319A1 Agents with serotonin-related activity for the treatment for sleep apnea |
| 09/02/1999 | WO1999043314A1 Farnesyl-protein transferase inhibitors |
| 09/02/1999 | WO1999043303A1 Method for producing encased spherical granular grains |
| 09/02/1999 | WO1999043286A2 Isolated stromal cells for use in the treatment of diseases of the central nervous system |
| 09/02/1999 | WO1999043285A2 Sulphonamide derivatives |
| 09/02/1999 | WO1999043271A1 Injectable implants for tissue augmentation and restoration |
| 09/02/1999 | WO1999043217A1 Use of d-tagatose as a prebiotic food component |
| 09/02/1999 | WO1999043210A1 Method for decreasing qt dispersion or inhibiting the progression of qt dispersion with an angiotensin ii receptor antagonist |
| 09/02/1999 | WO1999033841A3 Pyrrolothiazine and pyrrolothiazepine compounds having serotonin-2 receptor antagonistic and alpha-1-blocking action |
| 09/02/1999 | WO1999032085A3 Novel pharmaceutical compositions of uridine triphosphate |
| 09/02/1999 | WO1999030720A8 Method for inhibiting cyclooxygenase-2 and tumor necrosis factor alpha |
| 09/02/1999 | WO1999026632A8 Phospholipids having antimicrobial activity with or without the presence of antimicrobials |
| 09/02/1999 | WO1999023105A9 Vegi, an inhibitor of angiogenesis and tumor growth |
| 09/02/1999 | WO1999021540A3 Method of reducing craving in mammals |
| 09/02/1999 | WO1999002711A3 Fusion proteins with an immunoglobulin hinge region linker |
| 09/02/1999 | WO1998034632A9 Compounds and compositions for delivering active agents |
| 09/02/1999 | WO1998030693A9 Tumor necrosis factor receptor 5 |
| 09/02/1999 | CA2792479A1 Vaccines, immunotherapeutics and methods for using the same |
| 09/02/1999 | CA2324452A1 A living chimeric skin replacement |
| 09/02/1999 | CA2322167A1 Substituted cycloalkyl-4-oxonicotinic carboxamides; gaba brain receptor ligands |
| 09/02/1999 | CA2322163A1 Inhibitors of phospholipase a2 |
| 09/02/1999 | CA2322162A1 Inhibitors of phospholipase enzymes |
| 09/02/1999 | CA2322161A1 Inhibitors of phospholipase enzymes |
| 09/02/1999 | CA2322160A1 Vaccines, immunotherapeutics and methods for using the same |
| 09/02/1999 | CA2322139A1 Sulphonamide derivatives |
| 09/02/1999 | CA2321883A1 Isolated stromal cells for use in the treatment of diseases of the central nervous system |
| 09/02/1999 | CA2321870A1 Cell cycle related proteins |
| 09/02/1999 | CA2321869A1 Human proteinase molecules |
| 09/02/1999 | CA2321830A1 Benzylpiperazinyl- and benzylpiperidinyl ethanone derivatives, their preparation and their use as dopamine d4 receptor antagonists |
| 09/02/1999 | CA2321747A1 Human smn-like protein |